Ex-Juno executive details plans for new Seattle biotech


Sana came out of stealth mode in January and CEO Steve Harr said it will grow quickly in Boston, San Francisco and Seattle.

Previous Hopkins, Emocha win CDC funding to study effect of financial incentives on addiction recovery
Next Main Line Health joins growing list of health systems raising minimum pay